Clinical Trial Update: A Study to Assess the Safety and Immunogenicity of the Malaria Vaccine, R21, With Matrix-M1 Adjuvant [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update for the malaria vaccine R21 with Matrix-M1 adjuvant across Phase 1 and Phase 2 evaluating safety and immunogenicity; study completed wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• Matrix-M1 (Matrix-M1)
• R21

Snippet

Sponsor: University of Oxford | Conditions: Malaria | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2019-11-06